NDA’s Dr. Thomas Lönngren has been invited to speak at the launch of a new report entitled
Licensed to Cure?, being held at The Kohn Centre on Wednesday March 12th. The meeting is being run by UCL School of Pharmacy, supported by funding from the European Medicines Group.
This new publication investigates how organisations, such as NICE, value new treatments and discusses the use of unlicensed medicines as comparators in cost effectiveness appraisals.
The Licensed to Cure? report was authored by David Taylor, who has held a personal University of London chair in Pharmaceutical and Public Health Policy since 2000. He is a former NHS Trust chair and had responsibility for health care quality at the Audit Commission for England and Wales.
The meeting will be chaired by Ashok Soni, OBE FRPharmS.
For more information and to register please click here
Dr. Thomas Lönngren
Strategic advisor, NDA Group